MRI Assessment of Mode of Action of Bisacodyl, Single Dose
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Constipation
- Type
- Interventional
- Phase
- Phase 4
- Design
- Allocation: RandomizedIntervention Model: Crossover AssignmentIntervention Model Description: Phase IV, single center, double blind, randomized (1:1 ratio), two arms (bisacodyl and placebo), single-dose, and crossover clinical trial.Masking: Triple (Participant, Investigator, Outcomes Assessor)Masking Description: The study is a double blind study with a randomization ratio 1:1. The subjects, the investigator and the Sanofi team will be blinded to the treatment sequences allocation until the database lock. The medicinal product and placebo are indistinguishable using exactly the same packing and form.Primary Purpose: Basic Science
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04132661
- Collaborators
- Sanofi
- Investigators
- Principal Investigator: Robin Spiller, PhD University of Nottingham